Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents provides sound data on the utility of biological and plant-based drugs and describes challenges faced in all aspects offering indispensable strategies to use in the development of bioactive medicines. Bioactive based medications are commonly used throughout the world and have been recognized by physicians and patients for their therapeutic efficacy. Bioactive formulations, including their subordinates and analogs, address 50% of all medicines in clinical practice. Novel bioactive medicine transporters can cure many disorders by both spatial and transitory approaches and have various justifications in medicinal potential.
This book presents information on the utility of natural, plant, animal and bioengineered bioactive materials. It is a fundamental source of information and data for pharmacognosists, pharmaceutical analysts, drug transport scientists and pharmacologists working in bioactive medications.
- Advances information on various bioactive based medications, their sources, clinical consequences and transport strategies
- Illustrates diverse transport systems for bioactives and derivatives, novel techniques for formulations, targeting strategies and fundamental qualities of developed bioactive carriers, and their safety concerns and standardization
- Discusses distinctive transport systems, stability, upgraded dissolvability, and enhanced bioavailability of bioactives
Researchers and advanced students in pharmaceutical biotechnology, pharmaceutics, pharmacognosy, and natural science
1. Challenges and Need of Delivery carriers for bioactives and Biological agents: An Introduction
2. Natural product-based nanomedicine: polymeric nanocapsules as delivery cargoes of food bioactives and nutraceuticals for anticancer purposes
3. The promising expedition of the delivery systems for monoclonal antibodies
4. Innovative technological systems to optimize the delivery and therapeutic activity of antimicrobial drugs
5. Tailoring Drug and Gene Co-delivery Nanosystems for Glioblastoma Treatment
6. Polyelectrolyte multilayers for delivery of bioactives
7. Magnetic nanocarriers of bioactives: structural and delivery system designs
8. Iron bond bovine lactoferrin for treatment of anaemia associated with cancer cachexia
9. Metallic-based nanocarriers: Methods employed in nanoparticle characterization and assessing the interaction with the blood-brain barrier
10. Inorganic-based drug delivery systems of bioactives for cancer therapy
11. Novel perspectives for treatment of brain diseases with bioactives
12. Nanoparticle-based delivery of polyphenols for the treatment of inflammation-associated diseases
13. Efficacy of promising flavonoids from Festuca, Lonicera, and Acacia genera against Glioblastoma Multiform: potential for the Dandenong Ranges of Victoria, Australia
14. Targeting aspects for bioactive drugs
15. Amphiphilic Block Co Polymers: A Smart option for Bioactives delivery
16. Rheumatoid Arthritis: Basic Pathophysiology and role of chitosan nanoparticles in therapy
17. Targeted delivery through Carbon nanomaterials: Applications in bioactive delivery system
18. Liposomes and Phytosomes for Phytoconstituents
19. Quality by Design and Formulation optimization using statistical tools for safe and efficient bioactive loading
20. Commercial aspects and market potential of novel delivery systems for bioactives
- No. of pages:
- © Academic Press 2020
- 7th April 2020
- Academic Press
- Paperback ISBN:
- eBook ISBN:
Dr. Manju Rawat Singh is Assistant Professor, at Pt. Ravishankar Shukla University, India. She did her post doctoral research from University of Mississippi, Oxford, USA. She has around 14 years of teaching and research experience. Her prime research area includes designing strategies for protein and peptide delivery, topical systems for autoimmune disorders like psoriasis, rheumatoid arthritis, inflammatory bowel disease and experimental designing using advanced statistical and mathematical modeling methods. She has 75 research and review papers published in national and international journals. She has several ongoing projects funded by Indian council of medical research (ICMR), university grants commission (UGC), C.G. state council of science and technology (CGCOST), and Department of science and technology (DST). She is recipient of DHR-ICMR international fellowship 2014-15 and number of awards at national and state level for excellence in research.
Assistant Professor, Pt. Ravishankar Shukla University, India
Dr. Deependra Singh is Assistant Professor at Pt. Ravishankar Shukla University, India. He has around 15 years of teaching and research experience. His prime research area includes formulation of multiple bioactive delivery systems like multiphase hydrogels, nanosystems, microspheres, Designing strategies for fast and complete wound healing in normal and compromised wounds, Plant Tissue Culture Techniques and Development of novel systems for delivery of plant actives and extracts. He has 85 research and review papers published in national and international journals. He has several ongoing projects funded by university grants commission (UGC), C.G. state council of science and technology (CGCOST), and Department of science and technology (DST). He is a life member of various professional bodies like Indian Pharmaceutical association (IPA), Association of Pharmacy teachers of India (APTI), Indian Society of Pharmacognosy (ISP) and serving as President, Chhattisgarh state branch APTI 2013 (Elected), Secretary, Chhattisgarh state branch IPA.
Assistant Professor, Pt. Ravishankar Shukla University, India
Dr. Jagat Kanwar is Professor is the group leader and laboratory head of Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR) in School of Medicine, Faculty of Health at Deakin University, Australia. He has an international reputation in investigating fundamental and applied molecular aspects of cancer and chronic inflammation. He is an immunologist, molecular biologist and cell biologist. He has extensive training and expertise in studying the molecular mechanisms and in devising treatments for human diseases like cancer and chronic inflammatory diseases in both in vivo and in vitro models. His work has generated 12 patents/PCTs. Five of these patents have been licensed for commercialisation to biotech companies Antisoma, UK; Neurenpharma and NeuronZ, NZ. His research findings led to the development of novel ice-cream product ‘ReCharge’ with bovine lactoferrin and iron saturated milk lactoferrin as key ingredient and designated as the first medical food.
Professor and Laboratory Head, Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR) in School of Medicine, Faculty of Health, Deakin University, Australia
Dr. N.S. Chauhan is Senior Scientific Officer Grade-II and Government Analyst, Drugs Testing Laboratory avam Anusandhan Kendra (State Goverment lab of AYUSH). He has professional Expertise in Natural Product Isolation. Hands on in various techniques like extraction, isolation, and purification of natural products from plant extracts using various chromatographic techniques for separation of compounds includes column, LC-MS, chromatography, prep. TLC, Structure Elucidation Elucidation of structure of Natural Product with the help of various techniques like UV, Mass, IR and NMR. Biological experiments: Well versed with the design, conduct and data treatment of various in vivo experiments like Aphrodisiac, antidiabetic, antistress, hairgrowth, BPH, hepatoprotective Reproductive parameters. He has written more than 50 articles published in national and international journals, 20 book chapters. He is a member of various professional and academic bodies.
Senior Scientific Officer Grade-II and Government Analyst, Drugs Testing Laboratory avam Anusandhan Kendra (State Government lab of AYUSH), Raipur, India
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.